Search results
Jun 26, 2024 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
At Illumina, we have the opportunity to do work that transforms human health. Find genomics and biotech jobs at Illumina.
Reach out for information about our products and services or get answers to questions about our technology. *For in vitro diagnostic use. Contact an Illumina representative for regional availability. Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.
This detailed overview of Illumina sequencing describes the evolution of genomic science, major advances in sequencing technology, key methods, the basics of Illumina sequencing chemistry, and more. Read Introduction
View All. Maximize the effectiveness of your Illumina system, train new employees, or learn the latest techniques and best practices. We offer support webinars, online courses, expert video tips, and instructor-led trainings. Find Support Webinars and Online Training. Find Instructor-Led and Other Training.
Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. "The addition of Fluent BioSciences to Illumina will provide significant and new capabilities to our customers in a key growth area and advances our multiomics ...
